• M. I. Marushchak
  • I. Ya. Krynytska
  • G. G. Gabor
  • O. Z. Yaremchuk
Keywords: lung injury, pathogenesis.


Background. In contemporary life science research development most attention is paid to mechanisms of many human diseases that are associated with the violation in cell death. One of the main causes of cell thanatologic disregulation program is the changes in their production and activation of the biological effects of tumor alpha necrosis factor.
Objective is to summarize current scientific data about role of activated oxygen and nitric metabolites in the system of lung pathogenetic injuries.
Methods: analysis of the research data on mechanisms of lung injury.
Results and conclusions. The topical issue of lung pathogenetic injury is to understand the signs and mechanisms responsible for regulation of free radical oxidation and antioxidant defense system, the role of pro- and anti-inflammatory molecules, the influence of active metabolites on the process of restoration and survival of the respiratory tract cells in cases of acute lung injury. The studies of this processes will help to obtain more knowledge on lung pathology.


Parsons PE, Matthay MA, Ware LB, Eisner MD. National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005; 288: 426–431.

Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487–501.

Lundblad LK, Thompson-Figueroa J, Leclair T. TNF-alpha over-expression in lung disease: a single cause behind a complex phenotype. Am. J. Respir. Crit. Care Med. 2005; 171:1363–1371.

Marshall JC. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit. Care Med. 2001; 29: S99-S106.

Ware LB, Matthay MA. The acute respiratory distress syndrome. N. Engl. J. Med. 2000; 342: 1334–1349.

Varghese J, Ilias-basha H, Dhanasekaran R et al. Hepatopulmonary syndrome – past to present. Ann Hepatol. 2007; 6: 135–142.

Huffmyer JL, Nemergut EC. Respiratory dysfunction and pulmonary disease in cirrhosis and other hepatic disorders. Respir. Care. 2007; 52: 1030–1036.

Zhang HY, Han DW, Wang XC et al. Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome. World J. Gastroentеrol. 2005; 11: 567–572.

Maianski NA, Maianski AN, Kuijpers TW, Roos D. Apoptosis of neutrophils. Acta Haematol. 2004; 111: 56–66.

De Dooy JJ, Mahieu LM, Van Bever HP. The role of inflammation in the development of chronic lung disease in neonates. Eur. J. Pediatr. 2001; 160: 457–463.

Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr. Opin. Crit. Care. 2001; 7: 1–7.

Asai T, Ohno Y, Minatoguchi S. The specific free radical scavenger edaravone suppresses bleomycin-induced acute pulmonary injury in rabbits. Clin. Exp. Pharmacol. Physiol. 2007; 34: 22–26.

Tamagawa K, Taooka Y, Maeda A. Inhibitory effects of a lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Crit. Care Med. 2000; 161: 1279–1284.

Glosli H, Tronstad KJ, Wergedal H. Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes. FASEB J. 2002; 16: 1450–1452.

Ishii Y, Partridge CA, Del Vecchio PJ, Malik AB. Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. J. Clin. Invest. 1992; 89: 794–802.

Shiloh MU, MacMicking JD, Nicholson S. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity. 1999; 10: 29–38.

Sittipunt C, Steinberg KP, Ruzinski JT. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2001; 163: 503–510.

Tracey WR, Xue C, Klinghofer V. Immunochemical detection of inducible NO synthase in human lung. Am. J. Physiol. Lung Cell Mol. Physiol. 1994; 266: 722–727.

de Andrade JA, Crow JP, Viera L. Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografism. Am. J. Respir. Crit. Care Med. 2000; 161: 2035–2042.

Hiwari BS, Belenghi B, Levine A. Oxidative stress increased respiration and generation of reactive oxygen species, resulting in ATP depletion, opening of mitochondrial permeability transition, and programmed cell death. Plant Physiol. 2002; 128: 1271–1281.

Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2001; 163: 1376–1383.

Melley DD, Evans TW, Quinlan GJ. Redox regulation of neutrophil apoptosis and the systemic inflammatory response syndrome. Clin. Sci. 2005; 108: 413–424.

Mikhailov V, Mikhailova M, Degenhardt K. Association of Bax and Bak homo-oligomers in mitochondria. Bax requirement for Bak reorganization and cytochrome c release. J. Biol. Chem. 2003; 278: 5367–5376.

Choi IW, Sun-Kim, Kim YS. TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A (2) activation. J. Allergy Clin. Immunol. 2005; 116: 537–543.

Stepovaya EA, Zhavoronok TV, Starikov YuV. Regulyatornaya rol oksida azota v apoptoze neytrofilov. Byul. eksperim. biologii i meditsinyi. 2008; 146: 646–650.

Choi BM, Pae HO, Jang SI, Chung HT. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J. Biochem. Mol. Biol. 2002; 35: 116–126.

How to Cite
Marushchak, M. I., Krynytska, I. Y., Gabor, G. G., & Yaremchuk, O. Z. (2016). PATHOGENETIC MECHANISMS OF LUNG INJURY. International Journal of Medicine and Medical Research, 2(1), 54-58.